Literature DB >> 32133651

Risk of local recurrence of rectal cancer and circumferential resection margin: population-based cohort study.

E A Agger1, F H Jörgren2, M-L A Lydrup1, P L Buchwald1.   

Abstract

BACKGROUND: A circumferential resection margin (CRM) of 1·0 mm or less after rectal cancer surgery is thought to increase the risk of local recurrence (LR). This retrospective population-based study examined how CRM distance affects the LR risk.
METHODS: Data from the Swedish Colorectal Cancer Registry were used in a retrospective analysis of rectal cancers resected between 2005 and 2013. The primary endpoint was LR.
RESULTS: A total of 12 146 patients were identified, of whom 8392 were included in the analysis; 739 patients had a CRM of 1·0 mm or less and 7653 had a CRM larger than 1·0 mm. The mean follow-up time was 51 months. There were 66 LRs (8·9 per cent) in the group with a CRM of 1·0 mm or less, and 256 (3·3 per cent) among patients with a CRM larger than 1·0 mm. The LR rate was 17·0 per cent (27 of 159), 6·7 per cent (39 of 580), 1·9 per cent (2 of 103) and 3·4 per cent (254 of 7550) when the CRM was 0, 0·1-1·0, 1·1-1·9 and at least 2·0 mm respectively. The risk of LR among patients with a CRM of 0 mm was higher than that in all other subgroups with a larger CRM (P < 0·050). There was no difference in LR between the subgroups with CRM 1·1-1·9 mm and at least 2·0 mm. LR was diagnosed earlier when the CRM was 1·0 mm or less.
CONCLUSION: LR risk is related to exact CRM, with the highest risk in patients with a CRM of 0 mm. Close monitoring of patients with no measurable clear margin may allow early detection of LR.
© 2020 BJS Society Ltd Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2020        PMID: 32133651     DOI: 10.1002/bjs.11478

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  7 in total

1.  Omission of neoadjuvant radiotherapy for clinical T2/N1 and T3N0/1 middle and low rectal cancers with safe circumferential resection margins.

Authors:  Kyung-Ha Lee; Jin-Soo Kim; Ji-Yeon Kim
Journal:  Ann Surg Treat Res       Date:  2022-05-03       Impact factor: 1.766

2.  Comparison of Survival between Single-Access and Conventional Laparoscopic Surgery in Rectal Cancer.

Authors:  Siripong Sirikurnpiboon
Journal:  Minim Invasive Surg       Date:  2021-03-17

3.  Intraoperative adverse events as a risk factor for local recurrence of rectal cancer after resection surgery.

Authors:  Sophia Waldenstedt; David Bock; Eva Haglind; Björn Sjöberg; Eva Angenete
Journal:  Colorectal Dis       Date:  2022-01-10       Impact factor: 3.917

4.  Nomogram to predict permanent stoma in rectal cancer patients after sphincter-saving surgery.

Authors:  Chih-Yu Kuo; Po-Li Wei; Chia-Che Chen; Yen-Kuang Lin; Li-Jen Kuo
Journal:  World J Gastrointest Surg       Date:  2022-08-27

5.  A nomogram for predicting 10-year cancer specific survival in patients with pathological T3N0M0 rectal cancer.

Authors:  Shuang Liu; Shanfei Yang; Haina Yu; Huilong Luo; Gong Chen; Yuanhong Gao; Rui Sun; Weiwei Xiao
Journal:  Front Med (Lausanne)       Date:  2022-08-22

6.  Association of levels of metabolites with the safe margin of rectal cancer surgery: a metabolomics study.

Authors:  Shaopeng Zhang; Guoqiang Pan; Zhifeng Liu; Yuan Kong; Daguang Wang
Journal:  BMC Cancer       Date:  2022-10-05       Impact factor: 4.638

Review 7.  Surgical treatment of locally recurrent rectal cancer: a narrative review.

Authors:  Zhaoya Gao; Jin Gu
Journal:  Ann Transl Med       Date:  2021-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.